Connect with us

Published

on

Share on Pinterest In addition to the high price tag associated with drugs like Ozempic, Wegovy, and Mounjaro, several other costs you may not have anticipated can accumulate while youre taking weight loss medications. Phynart Studio/Getty ImagesSemaglutides like Wegovy and Ozempic reduce appetite and aid in weight loss and diabetes management. Walmart CEO John Furners comments about customers buying fewer units of food sent snack shares tumbling.Furner recently walked back comments, saying customers are purchasing more overall.Experts say people taking semaglutides may spend money on medications to manage side effects, new clothing that fits, and fitness equipment. However, doctors say that these potentially unexpected expenses are a drop in the bucket compared to the costs of the medications and access issues patients face.

Medications like semaglutide (sold under the brand names Ozempic and Wegovy), have skyrocketed in popularity due to their ability to help people lose weight.

In fact, research from 2021 suggested that a 2.4 mg dose of semaglutide (Wegovys dosing) could lower body weight when combined with lifestyle changes.

Anti-obesity medications like semaglutide, or Wegovy, fight the bodys physiological anti-starvation mechanisms by targeting the energy regulatory center of the brain, the hypothalamus, and addressing obesity-driven dysregulation in signaling pathways and hormone production, Dr. Katherine H. Saunders, DABOM, an obesity expert, co-founder of Intellihealth and clinical assistant professor of Medicine at Weill Cornell Medicine. Individuals who take semaglutide generally think about food differently, feel less hungry, feel full faster, and stay full for longer.

And thats how Walmart recently entered the discussion.

In early October, CEO John Furner told Bloomberg that shoppers taking semaglutide are purchasing less units, slightly less calories.

Business Insider noted that shares of Walmart snacks fell amid the news. Furner reportedly walked back statements in discussions with Morgan Stanley analysts, saying people taking the drug are spending more overall on items like medications to relieve side effects and lifestyle and fitness products.

Prescription drugs that aid with weight loss like Ozempic, Wegovy, and Mounjaro already come with a high price tag (around $1,000 a month without insurance), but people may not realize the cost of taking these medications likely wont end with the price of the drug alone.

For most patients, the benefits of the medication will likely outweigh most of these concerns, but its vital that patients understand the costs that could accumulate during treatment, says Dr. Christopher McGowan, a gastroenterologist, obesity medicine specialist, and the founder of True You Weight Loss. Are customers on weight-loss drugs spending less on food?

Early anecdotal evidence indicates that food companies are concerned or noticing shoppers taking drugs like Wegovy and Ozempic may be spending less on food.

Steve Cahillane, the CEO of Kellanova (Cheez-It, Pringles, and Rice Krispies Treats), said in an interview with Bloomberg that the business is assessing changes weight-loss medications may have on consumer behavior. In an interview with the Wall Street Journal, Smuckers CEO Mark Smucker made similar comments.

In the spring, the New York Post reported restaurants are changing menus and trimming portion sizes to adapt to customer eating habits amid a rise in semaglutide use, and that drumbeat has only grown louder.

Semaglutide changes appetites. Is it feasible that customers are spending or will spend less on food?

Its plausible.

It adds up that patients would consume less foods and, in that regard, buying less perishable items fits that story, says Dr. Konstantinos Spaniolas, the chief of the Division of Bariatric, Foregut, and Advanced GI Surgery at Stony Brook Medicine and the director of the Stony Brook Bariatric and Metabolic Weight Loss Center.

However, its also nuanced and too early to tell.

Individuals on semaglutide might spend less money on food because they eat less, but there are so many factors involved maybe theyre going out to eat more or eating higher quality or more expensive foods, Saunders says. Are there really hidden costs of Ozempic and Wegovy?

This answer also requires nuance.

First, experts say its important to discuss the benefits of weight-loss drugs.

In addition to weight loss, a 2023-published randomized control trial of 529 participants with obesity and heart failure suggested that those who took a 2.4 mg dose of semaglutide once weekly for 52 weeks had substantial improvements in symptoms and ability to function physically than the placebo group.

Novo Nordisk, which manufactures Ozempic, stopped a study on kidney failure in people with diabetes early because an independent data monitoring board recommended the evidence was strong enough to show it would succeed in helping this population.

However, the side effects and results from the drug may prompt consumers to purchase other items. The cost of managing side effects

Spaniolas says GI discomfort, including bloating and nausea, is a common side effect of patients on semaglutide. Another expert agrees and says additional medications arent the first-line treatment for managing these side effects.

For the vast majority of people, its manageable by lifestyle change, Dr. Angela Fitch, FACP, FOMA, the president of the Obesity Medicine Association and chief medical officer of knownwell, a weight-inclusive healthcare company. If you drink too much alcohol or eat too much for dinner, youll feel worse.

Fitch says fried foods like chicken and French fries can also make patients feel nauseous because they sit in the stomach longer.

For patients needing additional assistance managing side effects, medications may be necessary.

McGowan says he prescribes anti-nausea medications like ondansetron (brand-name for generic Zofran), which can retail for around $141 for a bottle of 20 pills.

Some patients may have severe gastrointestinal symptoms that necessitate emergency room visits, clinic appointments, and the need for IV hydration, McGowan says. Missed work due to side effects may result in financial impact.

ER visits can cost more than $1,000, according to American Family Care.

Fitch says that having an attentive care team that can adjust dosing and give insights on side effects and how to manage them can help prevent these costly ER visits. The cost of lifestyle products associated with weight loss drugs

Research indicates that semaglutide and similar medications are effective in helping patients living with overweight or obesity lose and maintain weight when combined with lifestyle changes.

Providers say these changes include physical activity. This need can come at a cost, too.

They also spend money on fitness equipment and gym memberships because cardio and strength training are critical strategies to preserve muscle mass and maintain weight loss long-term, Saunders says.

Costs of gym memberships vary based on the gym a person joins and the state, but Statista data from 2021 indicates monthly fees can range from $38 in Wyoming to more than $75 in New York.

Fitch says consumers may also purchase equipment for their homes.

The more you are losing weight, the better you feel, and you may buy a treadmill, Peloton, or hand weights, Fitch says. I can see a potential for an increase in those things.

Peloton bikes start at around $1,500, plus a membership fee that starts at $12.99 for the app. Prices on hand weights vary but can cost as low as $7 for a set of one, while larger sets can carry three-figure price tags.

Ultimately, Fitch says these costs are typically perceived as investments in health.

I think the data will be positive on quality and length of life, enjoyment of life, and being active, Fitch says.

For instance, the drugs and increased activity might also reduce costs associated with medical care for heart disease.

A new wardrobe may also be necessary to accommodate weight loss.

Our patients definitely sped money on new clothing as they lose weight, Saunders says. One inch on the waist is roughly equivalent to 8 pounds of lost weight.

But Saunders says patients are excited about the weight loss, and Fitch points out, You buy new clothes every time you gain weight.Accessing weight loss medication may cost you a lot of time too

Experts share that the most significant hidden cost of semaglutide (besides the drugs themselves) is time.

Given the supply shortages, patients frequently tell me they are forced to spend many hours contacting or driving to multiple pharmacies to acquire their medications or risk missing doses, which could jeopardize their progress, McGowan says.

Fitch has also noticed this issue.

To stay on Wegovy is like a full-time job. Fitch says, recalling a recent discussion with a patient whose mother stays home and found the drug for them. Thats not going to happen when you have three jobs and can barely make ends meet. Youre not going to call around to five pharmacies to access Wegovy.

And thats a problem.

These medications are not intended or designed for someone to take the medication to lose 20 or 30 pounds, and then once they lose it, you can stop your medications and move on with life, Spaniolas said. Once you stop them, the weight usually comes back.

Indeed, a trial of almost 2,000 people published in 2022 suggested that people who ceased use of 2.4 mg semaglutide doses had regained two-thirds of the lost weight within one year. The most significant cost: The semaglutide prescription itself

It doesnt help that insurance will not always cover these drugs for weight loss, and more companies are dropping coverage.

A 2003 law bars Medicare from covering weight loss drugs.

Without insurance coverage, the cost of the GLP-1 medications is prohibitive, McGowan says. The average retail price of Wegovy is $1,349. Its essential to keep in mind that that number is monthly every month.

That means a person will spend more than $16,000 annually out-of-pocket on Wegovy, a drug meant for long-term use.

The GLP-1 medications are chronic treatments intended to be used long-term, McGowan says. Therefore, that is not a cost-effective proposition. Tips to help manage the cost of weight loss drugs and related expenses

Not everyone can afford weight-loss drugs, and Saunders says that increased insurance coverage, lower prices, and shoring-up supply chain issues are among the greatest systemic issues that need to change.

Fitch says weight bias also plays a role in the approach to these drugs, including insurance coverage.

Were not asked to prove cost-effectiveness with any other disease, Fitch says. Its not cost-effective to treat cancerbut we dont let people die. But theres so much with obesity. Its a journey. Its a chronic disease, too.

In the interim, Saunders recommends patients:Speak with providers about ways to treat side effects other than medications, including eating habits.Invest in a fitness routine you can sustain, including aerobic and strength training that works for you.Find a care team that supports you. Even if you got lucky and lost weight relatively easily, you will inevitably hit bumps in the road during your weight journey, and youll need your care team to help you get back on track each time, Saunders says.

Spaniolas suggests giving yourself a whole serving of grace about expenses and access.

Youre doing the best you can with what is available to you, Spaniolas says. Takeaway

Food industry and retail executives and weight loss experts agree that its possible that weight loss drugs like Wegovy, Ozempic, and Mounjaro may influence purchasing behaviors.

Customers may spend less on food because of appetite reductions and more on fitness products, new clothes, and managing side effects of the drugs.

However, few people will lament this investment, McGowan says.

Experts say the most significant costs of these medications stem from supply-chain issues that have triggered drug shortages, making accessing them a full-time job. And thats if you can afford them.

Insurances do not always cover these drugs for weight loss, which cost more than $1,000 per month out of pocket, and more are announcing they will drop them.

Experts share this needs to change so people can access these drugs, which can better health outcomes beyond weight loss, including a reduction in heart disease symptoms.

Continue Reading

Sports

Canes win series, spoil Markstrom 49-save outing

Published

on

By

Canes win series, spoil Markstrom 49-save outing

After the New Jersey Devils saw their season end in double overtime Tuesday night, goaltender Jacob Markstrom wanted to express his frustration via his stick. He thought about boomeranging it to the boards. Instead, he swung it hard against his goalpost, breaking it in half.

Sebastian Aho‘s goal at 4:17 of the second overtime in Game 5 gave the Carolina Hurricanes a 5-4 win and a 4-1 series victory over the Devils. It was the first puck Markstrom had fly by him in 37 consecutive shots on goal, dating to the second period. That included 18 saves he made in overtime, as Carolina marauded a short-handed and exhausted Devils defense but couldn’t solve the 35-year-old goalie.

“That was one of the better goaltending performances that I’ve witnessed,” Hurricanes coach Rod Brind’Amour said of Markstrom, who finished with 49 saves. “He let in a few early that he’d like to have back. But once he got dialed in, you’re thinking it’ll have to bank off somebody, because we’re not beating him.”

Markstrom’s frustration wasn’t just with the overtime goal. The Devils built a 3-0 lead in the first period. Carolina scored three times in the first 5:40 of the second period to erase it. New Jersey responded with a Nico Hischier goal, only to have Aho knot the score at 4 moments later.

“We put up four goals on the road,” Markstrom said. “We should have brought it home. It should have been enough.”

But as his teammates noted, Markstrom’s effort in the overtimes should have been enough to win Game 5.

“We were under siege. He was outstanding. We were reeling,” coach Sheldon Keefe said.

“He played unbelievable. Marky kept us in that first overtime,” Hischier said. “I feel bad for him because he battled his ass off.”

Markstrom was acquired by the Devils last offseason in a high-profile deal with the Calgary Flames that was intended to fix the team’s goaltending, which ranked 30th in 2023-24. He won 26 times in 49 games with a .900 save percentage and a 2.50 goals-against average. He was outstanding, for the most part, in the playoffs: .911 save percentage and a 2.78 goals-against average in five games.

But Markstrom couldn’t overcome two things in the postseason for the Devils. The first were their injuries. Already without star center Jack Hughes, who had season-ending shoulder surgery, the Devils saw defensemen Luke Hughes, Johnathan Kovacevic and Brenden Dillon leave the series with injuries, with defensemen Jonas Siegenthaler and Dougie Hamilton playing at less than 100%.

“We had a few guys go down in the series. A few guys step up and battle. We’ve got to get better. We don’t like the result,” forward Timo Meier said.

The other factor was the Devils special teams. Their power play was officially 0-for-15. Their penalty kill allowed six goals on 19 Carolina power plays.

“That’s why we lost the series for sure. We couldn’t get the power play going. That’s on those guys, including me, that are on the ice. That’s definitely frustrating,” Hischier said.

But the Devils gutted out the series, pushing Carolina to double overtime in an elimination game despite those deficiencies.

“There’s a lot of will in this room,” Markstrom said. “It sucks right now.”

Continue Reading

Sports

Yanks make history by again opening with 3 HRs

Published

on

By

Yanks make history by again opening with 3 HRs

BALTIMORE — The New York Yankees became the first team in major league history to open a game with three consecutive home runs more than once in a season when Trent Grisham, Aaron Judge and Ben Rice went deep off Baltimore‘s Kyle Gibson in the first inning Tuesday night.

New York started the bottom of the first of its March 29 game against Milwaukee with three homers in a row. In that game, Paul Goldschmidt, Cody Bellinger and Judge needed only three pitches to hit three homers.

The Yankees added a fourth home run later in the first inning of both that game and Tuesday’s game, making them the first team to belt four in the first inning twice in a season.

On Tuesday night, the Yankees hit three of the game’s first five offerings out to right field.

“Grish got it going for us and set the tone for us early on,” Judge said after the 15-3 win. “When he goes up there and … sends one to Eutaw Street, it’s pretty impressive and gets you going.”

It was an ugly return to the majors for the 37-year-old Gibson, who made 30 starts for the St. Louis Cardinals last season before Baltimore signed him to a $5.25 million, one-year contract in late March. He’d been working in the minors since then before being called up before Tuesday’s game. He was finally pulled with two outs in the fourth after allowing nine runs and 11 hits.

“He gave up four homers in the first inning. That’s kind of a telling sign,” Orioles manager Brandon Hyde said. “At that point I’m just trying to figure out how we’re going to get through the game.”

After Rice’s home run made it 3-0, Gibson retired Goldschmidt on a grounder before Bellinger also homered. Anthony Volpe‘s RBI double made it 5-0 before the first inning was over.

Rice homered again in the second to make it 6-0. Austin Wells hit New York’s final home run — all six came with nobody on — with two outs in the ninth.

“It just shows that we’ve got a lot of depth in the lineup,” Rice said.

Not all the news was great for the Yankees, however. Jazz Chisholm Jr. left the game with right flank discomfort in the first inning.

Chisholm, who is hitting .181 with seven home runs this season, appeared to have hurt himself while he was batting. After being checked on, he stayed at the plate and hit a double, advancing to third on an error by right fielder Ramon Laureano.

Chisholm said he wasn’t worried about needing to go on the injured list.

“I’m really not as concerned as everybody else,” Chisholm said. “I tore my oblique before. I know it’s not torn or anything.”

The Associated Press and ESPN Research contributed to this report.

Continue Reading

Sports

DeGrom gets 1st win in 2 years as Rangers rip A’s

Published

on

By

DeGrom gets 1st win in 2 years as Rangers rip A's

ARLINGTON, Texas — Everything came together in the same game for two-time Cy Young Award winner Jacob deGrom and the Texas Rangers batters.

Texas had a much-needed offensive breakout while deGrom struck out seven over six scoreless innings for his first win in more than two years, though he had pitched well enough to win in several other starts this season.

“When was the last one, ’23? Yeah, it’s been a while,” deGrom said after the Rangers’ 15-2 win over the Athletics on Tuesday night.

“He earned it. He had great stuff tonight, he kept us on our toes,” second baseman Marcus Semien said. “We were just talking about how the time of possession was. You know, we were hitting for a long time and he’s getting quick outs. So usually that’s a good recipe.”

The 36-year-old deGrom (1-1) had gone 737 days since also beating the A’s on April 23, 2023, then made only one more start in his debut season with Texas before Tommy John surgery.

He scattered four singles and didn’t walk a batter in a 65-pitch outing (47 strikes). It was only that short since the right-hander didn’t return after an eight-run outburst in the Rangers sixth that matched their previous season high for runs in an entire game and put them up 12-0.

So just how efficient was deGrom? The right-hander honestly thought he was “probably in the 70s or something to 80,” as did catcher Jonah Heim.

“A lot a strikeouts that I feel like he just overpowered a lot of hitters, which is who he is. He’s got that electric fastball,” Heim said.

“My mechanics were pretty good,” said deGrom, a meticulous worker who was feeling good after a side session the day before the game. “I’m constantly trying to perfect it and get in the best positions that I can get based on performance and health.”

Texas entered the night last in the majors with 91 runs scored, and only 12 combined the previous six games. DeGrom had gotten only nine runs of support in his first five starts.

The Rangers snapped a three-game losing streak while setting season highs for runs, hits (18) and walks (nine). They had three bases-clearing doubles in the same game for the first time in team history – Adolis García and Wyatt Langford each had one during a four-batter stretch in that big sixth, and Kyle Higashioka added his three-run double in the eighth.

Their offensive outburst came after the full squad was required to be on the field for batting practice before the game.

“Good to see you guys break out and have a good game. … Some success, it’s contagious,” manager Bruce Bochy said. “You’re hoping this is something these guys can build on, build some confidence.”

For deGrom, he improved to 3-1 with a 2.55 ERA in his 15 starts for the Rangers since signing a $185 million, five-year contract in December 2022. He is 85-58 in 224 career starts, the first 209 with the New York Mets from 2014-2022.

“He was really good tonight. You know, I said when season started, it’s just going to get better with him as he builds up his strength and stamina,” Bochy said. “Really good command tonight, really good stuff. And it’s just getting better with him.”

Continue Reading

Trending